1. Home
  2. GKOS vs EAT Comparison

GKOS vs EAT Comparison

Compare GKOS & EAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$116.08

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Brinker International Inc.

EAT

Brinker International Inc.

HOLD

Current Price

$150.66

Market Cap

5.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
EAT
Founded
1998
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.0B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
EAT
Price
$116.08
$150.66
Analyst Decision
Strong Buy
Buy
Analyst Count
13
16
Target Price
$125.54
$165.00
AVG Volume (30 Days)
865.8K
1.5M
Earning Date
10-29-2025
01-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
136.76
EPS
N/A
9.64
Revenue
$469,820,000.00
$5,594,400,000.00
Revenue This Year
$31.15
$7.80
Revenue Next Year
$24.15
$5.17
P/E Ratio
N/A
$15.49
Revenue Growth
30.38
23.18
52 Week Low
$73.16
$100.30
52 Week High
$163.71
$192.22

Technical Indicators

Market Signals
Indicator
GKOS
EAT
Relative Strength Index (RSI) 76.42 64.92
Support Level $105.88 $143.52
Resistance Level $116.72 $154.83
Average True Range (ATR) 3.26 6.46
MACD 0.07 0.07
Stochastic Oscillator 94.61 79.71

Price Performance

Historical Comparison
GKOS
EAT

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About EAT Brinker International Inc.

Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.

Share on Social Networks: